[Esomeprazole-induced subacute cutaneous lupus erythematosus]. 2011

J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo

UI MeSH Term Description Entries
D008178 Lupus Erythematosus, Cutaneous A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute ( Lupus Erythematosus, Cutaneous, Subacute,Lupus Erythematosus, Subacute Cutaneous,Cutaneous Lupus Erythematosus
D011244 Pregnadienediols Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains. Dihydroxypregnadienes
D011537 Pruritus An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. Itching,Pruritis
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068656 Mometasone Furoate A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders. Asmanex,Asmanex Twisthaler,Elocon,Mometasone,Mometasone Furoate Monohydrate,Nasonex,Rinelon,Sch 32088,Sch-32088,Furoate Monohydrate, Mometasone,Furoate, Mometasone,Monohydrate, Mometasone Furoate,Sch32088,Twisthaler, Asmanex
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
March 2008, The British journal of dermatology,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
February 2008, Cutis,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
May 2020, Dermatologic therapy,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
August 2010, Lupus,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
December 1998, The British journal of dermatology,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
November 2001, Rheumatology (Oxford, England),
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
May 2006, Journal of the American Academy of Dermatology,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
August 2016, Cutis,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
January 2003, European journal of dermatology : EJD,
J Alcántara-González, and M T Truchuelo-Díez, and C González-García, and P Jaén Olasolo
September 2022, The Kaohsiung journal of medical sciences,
Copied contents to your clipboard!